Clinical Trial Update: Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the safety of pembrolizumab in patients with unresectable or metastatic melanoma or non-small cell lung cancer in India. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Carcinoma, Non-Small-Cell Lung, Melanoma | Phase 4 | Status: COMPLETED | Results posted: 2025-08-29